Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Several correspondents have criticised the HOPE investigators
for focusing on relative effects when the absolute benefit was very
small. Twisselmann, in her summary of many responses on the website,
comments: "It was noted that only the relative risk reduction was
given in the study. This should have been accompanied by data on
absolute risk reduction and number needed to treat and even number
needed to harm (as per CONSORT guidelines)."1
This sentence may accurately reflect comments on bmj.com, but it misrepresents the CONSORT statement. Although we agree that in many cases it is helpful to present results as both reduction in relative risk and reduction in absolute risk, CONSORT makes no such recommendation.
Badrinath observes that if general agreement is reached then the next
CONSORT guidelines should include a statement that, whenever applicable
the results of clinical trials should include the numbers needed to
treat.1 Clearly, no such